Cambridge Investment Research Advisors, Inc. - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 220 filers reported holding FIBROGEN INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of FIBROGEN INC
ValueSharesWeighting
Q1 2022$128,000
-14.7%
10,6310.0%0.00%0.0%
Q4 2021$150,000
+35.1%
10,631
-1.8%
0.00%0.0%
Q3 2021$111,000
-46.6%
10,831
+80.5%
0.00%0.0%
Q1 2021$208,000
-34.0%
6,000
-29.4%
0.00%
-50.0%
Q4 2020$315,000
-27.1%
8,500
-19.1%
0.00%
-33.3%
Q3 2020$432,000
-7.1%
10,509
-8.5%
0.00%0.0%
Q2 2020$465,000
+18.0%
11,484
+1.2%
0.00%
-25.0%
Q1 2020$394,000
-19.8%
11,350
-0.8%
0.00%0.0%
Q4 2019$491,000
+19.2%
11,438
+2.6%
0.00%0.0%
Q3 2019$412,000
-18.3%
11,1500.0%0.00%
-20.0%
Q2 2019$504,00011,1500.01%
Other shareholders
FIBROGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders